Literature DB >> 12477874

Expression of CXCR4 on feline peripheral blood mononuclear cells: effect of feline immunodeficiency virus infection.

Brian J Willett1, Celia A Cannon, Margaret J Hosie.   

Abstract

CXCR4 expression on feline peripheral blood mononuclear cells (PBMC) was analyzed. While monocytes and B lymphocytes expressed CXCR4, no CXCR4 was detected on T lymphocytes, in stark contrast to the expression pattern on T lymphocytes from humans. In spite of the important role that CXCR4 plays in infection with feline immunodeficiency virus, expression on PBMC in vivo was unaffected by infection with either a primary or a cell culture-adapted virus strain.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12477874      PMCID： PMC140578          DOI： 10.1128/jvi.77.1.709-712.2003

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  23 in total

1.  Dual personality of memory T cells.

Authors:  C R Mackay
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.

Authors:  B Lee; M Sharron; L J Montaner; D Weissman; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Inhibitory effect of stromal cell derived factor-1 on the replication of divergent strains of feline immunodeficiency virus in a feline T-lymphoid cell line.

Authors:  Y Endo; Y Goto; Y Nishimura; T Mizuno; T Watari; A Hasegawa; T Hohdatsu; H Koyama; H Tsujimoto
Journal:  Vet Immunol Immunopathol       Date:  2000-05-23       Impact factor: 2.046

4.  CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.

Authors:  J K Nicholson; S W Browning; R L Hengel; E Lew; L E Gallagher; D Rimland; J S McDougal
Journal:  J Acquir Immune Defic Syndr       Date:  2001-06-01       Impact factor: 3.731

5.  Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.

Authors:  A de Parseval; J H Elder
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 6.  The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus.

Authors:  B J Willett; M J Hosie
Journal:  Mol Membr Biol       Date:  1999 Jan-Mar       Impact factor: 2.857

7.  Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus.

Authors:  J Richardson; G Pancino; R Merat; T Leste-Lasserre; A Moraillon; J Schneider-Mergener; M Alizon; P Sonigo; N Heveker
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.

Authors:  H F Egberink; E De Clercq; A L Van Vliet; J Balzarini; G J Bridger; G Henson; M C Horzinek; D Schols
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  In vivo monocyte tropism of pathogenic feline immunodeficiency viruses.

Authors:  S W Dow; C K Mathiason; E A Hoover
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

10.  Antigenically distinct conformations of CXCR4.

Authors:  F Baribaud; T G Edwards; M Sharron; A Brelot; N Heveker; K Price; F Mortari; M Alizon; M Tsang; R W Doms
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103
View more
  8 in total

1.  Generation of feline dendritic cells derived from peripheral blood monocytes for in vivo use.

Authors:  Giulia Freer; Donatella Matteucci; Paola Mazzetti; Leonia Bozzacco; Mauro Bendinelli
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

Review 2.  Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.

Authors:  Brian J Willett; Margaret J Hosie
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

3.  In vivo CXCR4 expression, lymphoid cell phenotype, and feline immunodeficiency virus infection.

Authors:  Sean P Troth; Alan D Dean; Edward A Hoover
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

4.  Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligand.

Authors:  Brian J Willett; Elizabeth L McMonagle; Nicola Logan; O Brad Spiller; Pascal Schneider; Margaret J Hosie
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

5.  Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase.

Authors:  C D Eckstrand; C Hillman; A L Smith; E E Sparger; B G Murphy
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

Review 6.  Virus-host interaction in feline immunodeficiency virus (FIV) infection.

Authors:  Sueli Akemi Taniwaki; Andreza Soriano Figueiredo; João Pessoa Araujo
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2013-08-02       Impact factor: 2.268

7.  Feline hypertrophic cardiomyopathy: reduced microvascular density and involvement of CD34+ interstitial cells.

Authors:  Josep M Monné Rodríguez; Sonja Fonfara; Udo Hetzel; Anja Kipar
Journal:  Vet Pathol       Date:  2021-12-27       Impact factor: 2.221

8.  Genetically divergent strains of feline immunodeficiency virus from the domestic cat (Felis catus) and the African lion (Panthera leo) share usage of CD134 and CXCR4 as entry receptors.

Authors:  William A McEwan; Elizabeth L McMonagle; Nicola Logan; Rodrigo C Serra; Pieter Kat; Sue Vandewoude; Margaret J Hosie; Brian J Willett
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.